Last reviewed · How we verify
BCD-066
At a glance
| Generic name | BCD-066 |
|---|---|
| Also known as | darbepoetin alfa |
| Sponsor | Biocad |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
- monocytes count increase
- thrombocytes count increase
- Neutrophis count decrease
- Hematocrit decrease
- Hemoglobin decrease
- WBC decrease
- RBC decrease
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BCD-066 CI brief — competitive landscape report
- BCD-066 updates RSS · CI watch RSS
- Biocad portfolio CI